The Workforce AI Index · Healthcare
Johnson & Johnson (JNJ)
Medicines and devices by description. Read October 1, 2026 from the annual report for the period ending 2025-12-28, filed 2026-02-11. Ranked 23 of the 27 Healthcare companies read so far, by the share within reach now: the sector.
The filing states employees and full-time equivalents but nothing by segment, so the pharmaceutical and device patterns follow the description of its two segments.
The figures on this page come from the company's own annual report and from BLS staffing patterns for its industries, never from a roster. They are estimates with a stated method. Nothing here says what the company will do: within reach is not a forecast of jobs lost or of savings.
What follows from the reading
Share of working time within reach of AI, on the long-run pace at four in five: 18% now, 32% at the end of 2027, 38% at the end of 2028, 41% at the end of 2030. By the patterns, the work is about 41% desk work, 15% people work and 44% body work. These are the site's industry estimates weighted by the shares below: estimates with a stated method and range, not a forecast of what the company will do. By the same patterns, at the end of 2028 about 56% of the working time stays with people (conversation, in-person and hands-on work), 36% becomes checking a model's work and 5% could be handed over with lighter checks, from the industries' own figures, not the company's roles.
Headcount
140,800 employees as of 2025-12-28 (stated). The filing does not state a count by country in the text read.
The filing: “As of December 28, 2025 and December 29, 2024 the number of employees was approximately: Employees 140,800 and 139,800; full-time equivalent (FTE) positions 138,200 and 138,100.”
The workforce as industry patterns
| Pattern | Share | Reason, from the filing |
|---|---|---|
| Pharmaceutical and Medicine Manufacturing | 55% | By (c): the filing states the total and the full-time equivalent count but no headcount by segment, and describes Innovative Medicine as the larger of its two segments, so the larger share is read into the pharmaceutical manufacturing pattern by description, with research and sales staff inside it as BLS counts a maker's staff. |
| Medical Equipment and Supplies Manufacturing | 45% | By (c): the MedTech segment, devices for surgery, orthopaedics, vision and cardiovascular care, is described without a headcount, so the rest is read into the medical equipment manufacturing pattern by description. |
What the filing says about the workforce: About 140,800 employees and 138,200 full-time equivalent positions; the collector's first reading took the FTE figure.
Companies read with the same leading pattern
Other companies whose largest staffing pattern is also Pharmaceutical and Medicine Manufacturing, largest first, each read from its own annual report. Within reach now and at the end of 2028, long-run pace, four in five.
- Thermo Fisher Scientific Inc. (TMO, 125,000 employees)19% now, 48% by 2028
- Merck & Co., Inc. (MRK, 75,000 employees)17% now, 40% by 2028
- Pfizer Inc. (PFE, 75,000 employees)17% now, 40% by 2028
- AbbVie Inc. (ABBV, 57,000 employees)17% now, 40% by 2028
What the filing says about AI
6 sentences in the filing name AI. The filing says the company 'leverages the use of data science, machine learning and other forms of AI' across parts of its business and names the broad availability of generative AI among the trends it faces; the human capital section does not mention it.
- “In the EU, multiple directives and laws (including NIS2, EHDS, the Data Act, the Cyber Resilience Act, and the AI Act) are rapidly changing privacy and cybersecurity compliance requirements while introducing new enforcement risks.”
- “Moreover, as a result of the broad scale release and availability of Artificial Intelligence (AI) technologies such as generative AI, a global trend towards more comprehensive and nuanced regulation to ensure the ethical use, privacy, and security of AI is underway that includes standards for transparency, accountability, and fairness, which will require compliance developments or enhancements.”
- “The Company leverages the use of data science, machine learning and other forms of AI and emerging technologies across varying parts of its business and operations, and the introduction and incorporation of AI may result in unintended consequences or other new or expanded risks and liabilities.”
- “AI technology is continuously evolving, and the AI technologies we develop and adopt may become obsolete earlier than planned.”
- “The application of AI in our business is emerging and evolving alongside new laws and regulations that may entail significant costs or ultimately limit our ability to continue the use of these technologies.”
Headcount by filing year
As reported in each year's annual report, with the filing. A year marked not read had no figure the reading could take from the report's text.
| Period | Employees | Filed | Filing |
|---|---|---|---|
| 2025-12-28 | 138,200 | 2026-02-11 | 10-K |
| 2024-12-29 | 138,100 | 2025-02-13 | 10-K |
| 2023-12-31 | 131,900 | 2024-02-16 | 10-K |
| 2023-01-01 | 152,700 | 2023-02-16 | 10-K |
| 2022-01-02 | 141,700 | 2022-02-17 | 10-K |
| 2021-01-03 | 134,500 | 2021-02-22 | 10-K |
| 2019-12-29 | 132,200 | 2020-02-18 | 10-K |
| 2018-12-30 | 135,100 | 2019-02-20 | 10-K |
| 2017-12-31 | 134,000 | 2018-02-21 | 10-K |
| 2017-01-01 | 126,400 | 2017-02-27 | 10-K |
| 2016-01-03 | 127,100 | 2016-02-24 | 10-K |
| 2014-12-28 | 126,500 | 2015-02-24 | 10-K |
| 2013-12-29 | 128,100 | 2014-02-21 | 10-K |
| 2012-12-30 | 127,600 | 2013-02-22 | 10-K |
| 2012-01-01 | 117,900 | 2012-02-23 | 10-K |
| 2011-01-02 | 114,000 | 2011-02-25 | 10-K |
| 2010-01-03 | 115,500 | 2010-03-01 | 10-K |
| 2008-12-28 | 118,700 | 2009-02-20 | 10-K |
| 2007-12-30 | 119,200 | 2008-02-26 | 10-K |
| 2006-12-31 | 122,200 | 2007-02-21 | 10-K |
| 2006-01-01 | 115,600 | 2006-03-14 | 10-K |
| 2005-01-02 | 109,900 | 2005-03-15 | 10-K |
| 2003-12-28 | 110,600 | 2004-03-11 | 10-K |
| 2002-12-29 | 108,300 | 2003-03-18 | 10-K |
| 2001-12-30 | 101,800 | 2002-03-20 | 10-K |
| 2000-12-31 | 98,500 | 2001-03-30 | 10-K405 |
| 2000-01-02 | 97,800 | 2000-03-31 | 10-K405 |
| 1999-01-03 | 93,100 | 1999-04-01 | 10-K |
| 1997-12-28 | 90,500 | 1998-03-27 | 10-K405 |
| 1996-12-31 | 89,300 | 1997-03-31 | 10-K405 |
| 1995-12-31 | 82,300 | 1996-04-01 | 10-K405 |
| 1995-01-01 | 81,500 | 1995-04-03 | 10-K405 |
| 1994-01-02 | 81,600 | 1994-04-01 | 10-K |
Limits of this reading
- No headcount by segment is stated; both pattern shares follow the business description (c).
- The U.S. share is not stated in the text read.
Source: the company's annual report on EDGAR, accession 0000200406-26-000016, the filing. Read by Claude Fable 5.1 under rubric version 1, by the method. A company can write to info@stratussc.com to have its reading checked against its filing.
Questions about this company
- How much of Johnson & Johnson's working time is within reach of AI?
- An estimated 18% now and 38% by the end of 2028, on METR's long-run pace at four in five, from the workforce Johnson & Johnson's own annual report describes and BLS staffing patterns for its industries, never from a roster. It is an estimate with a stated method. It is not a forecast of jobs lost or of savings, and it says nothing about what the company will do.
- How many people does Johnson & Johnson employ?
- 140,800 as of December 28, 2025, as its annual report for the period ending December 28, 2025 states.
- What kinds of work make up Johnson & Johnson's workforce?
- Read from its annual report as a blend of 2 industry staffing patterns, the largest Pharmaceutical and Medicine Manufacturing; by those patterns the work is about 41% desk work, 15% people work and 44% body work. Each share has a one-sentence reason on this page that can be checked against the filing.
- What does Johnson & Johnson's annual report say about AI?
- 6 sentences in the filing name AI. They are counted and quoted on this page, never judged: a count says how much a filing talks about AI, not what the company does with it.
- How is this estimated?
- Claude Fable 5.1 read the annual report under the Index's written rubric (version 1) on October 1, 2026: the stated headcount, the share in the U.S. when stated, and the workforce as a blend of industry staffing patterns. The estimates are the site's industry estimates weighted by those shares, from O*NET tasks with estimated lengths and METR's measurements of how long a task AI models can finish. A company can write to info@stratussc.com to have its reading checked against its filing.
Embed these figures on your site
A small card with the share of working time within reach now and at the end of 2027, 2028 and 2030, the date and a link back. Free under CC BY 4.0; the card carries the credit.